Abstract
Objectives: To review the characteristics, efficacy, safety, pharmacoeconomics, and place in therapy of upadacitinib, a Janus kinase (JAK) inhibitor, ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
